Stool Softener Laxative Tablet
NDC Package 21130-855-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Stool Softener Laxative (docusate sodium and sennosides) tablets is take only by mouth. This formulation utilizes a tablet delivery system. Marketed by Safeway, Inc., this product is identified by NDC 21130-855 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
21130-855-20
Package Description
200 TABLET in 1 BOTTLE, PLASTIC
Product Code
21130-855
11-Digit Billing Format
21130085520
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Stool Softener Laxative
Non-Proprietary Name
Docusate Sodium And Sennosides
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Take only by mouth. Doses may be taken as a single daily dose, preferably in the evening, or in divided dosesadults and children 12 years and oldertake 2-4 tablets daily children 6 to under 12 years of agetake 1-2 tablets daily children 2 to under 6 years of agetake up to 1 tablet daily children under 2ask a doctor 

Regulatory & Marketing

Labeler Name
Safeway, Inc.
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-29-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21130-855-20 identifies a specific commercial package of 200 tablet in 1 bottle, plastic of Stool Softener Laxative, a human over the counter drug labeled by Safeway, Inc.. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Safeway, Inc. on January 29, 2021. The current certification is valid through December 31, 2026.

How is this Safeway, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21130085520. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21130-855-20
11-Digit CMS (5-4-2)
21130-0855-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.